Former British Prime Minister David Cameron, Medical Leaders and Researchers from around the World Convene in Cleveland to Discuss Drug Development Progress
Harrington Discovery Institute at University Hospitals Holds 12 th Annual Scientific Symposium
CLEVELAND, May 23, 2025 /CNW/ -- Harrington Discovery Institute at University Hospitals held its 12 th annual scientific symposium this week. Scientific researchers and leaders from across the globe gathered in Cleveland, Ohio to discuss progress being made in drug development for a variety of conditions, including Alzheimer's and rare diseases.
Symposium speakers included former UK Prime Minister, David Cameron, who chairs the Advisory Council for the Oxford-Harrington Rare Disease Centre — a unique transatlantic partnership between the University of Oxford, UK, and Harrington Discovery Institute at University Hospitals in Cleveland, aimed at driving breakthrough treatments for rare diseases. These diseases typically lack commercial incentive for private companies to develop therapies and treatments. Researchers often find their work at a standstill in the so-called Valley of Death — the chasm between discoveries that could not be funded and the funding sources that would not fund them.
The Advisory Council supports the OHC's mission to deliver new treatments for the estimated half a billion people affected by rare diseases worldwide. Council members are leaders of relevant industries and sectors from different regions of the world who bring expertise, resources and networks towards the initial goal of developing 40 new drugs for rare diseases in the next 10 years.
Harrington scholars presented their latest discoveries throughout the two-day scientific symposium. Of the 8,000 physician-scientists in the US, nearly 50 percent have sought support from Harrington Discovery Institute. To date 150 of those Harrington Scholars have drugs-in-the-making, more than 30 have created new companies, and four are in Phase 3 clinical trials — for heart attacks, macular degeneration, Alzheimer's, and a rare cancer syndrome. Another scholar's therapeutic for babies with spina bifida is in a potentially pivotal clinical trial.
To achieve these results, Harrington Discovery Institute created an innovation pathway consisting of creative science, drug development assistance, business strategy support, and strong management.
David Cameron, Chair of the OHC's Advisory Council, said: " T he work of Harrington Discovery Institute is second to none. It's rare to find an organization that not only funds but also surrounds researchers with a full infrastructure to move discoveries forward. To be truly transformational, genomics requires the best of academia, life sciences, pharmaceutical companies, philanthropy and venture capital from around the world to come together. That is what the Oxford-Harrington Rare Disease Centre sets out to do, convening those key players and uniting around a bold mission. I have long championed improvements in healthcare through research, and I am proud to be aligned with an organization that doesn't shy away from complex problems. Rare disease and Alzheimer's have been a focus personally and professionally and remain among my deepest commitments. Behind everyone is a family, a story, and a chance to change the future through science, and we owe it to patients and families to keep pushing the boundaries."
Jonathan S. Stamler, MD, President and co-founder of Harrington Discovery Institute, commented: "At Harrington Discovery Institute, we've created a powerful mission — to accelerate promising discoveries into medicines for unmet needs. We've also created results. Most notably, we have put many new medicines into the drug development system. By the numbers, we now have 214 drugs in the making, 43 companies launched, 23 medicines in the clinic, and 15 licenses to pharma. These are quality metrics. Leaders in pharma, biotech, and academia have said that results like these at any organization would be exceptional, let alone one built from within an academic medical center."
Cliff Megerian, University Hospitals CEO, added: "Harrington Discovery Institute is a shining example of what so many of us aspired to do when we became doctors — identify a problem, solve the problem, help others. Our mission at UH is: To Heal. To Teach. To Discover. We fulfill our commitment to the "Discover" part of our mission through Harrington Discovery — it's our mechanism for investing in our nation's best discoveries and brightest scholars to advance new cures. We're grateful to have attendees from across the US, the UK, and Canada — as well as those based right here in Cleveland at University Hospitals."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
2 days ago
- CTV News
Nova Scotia government creating engagement table to address gender-based violence
The Nova Scotia government is creating an engagement table to address gender-based violence in the province. The table, which will be led by Attorney General and Justice Minister Becky Druhan, will have up to 25 members. Members will include representatives of front-line service providers and community organizations, survivors, family members and academic experts. 'Nova Scotians have told us that gender-based violence supports and services need to be more connected, more responsive and easier to access,' said Druhan in a news release Tuesday. 'We need to work together with the people providing support and the survivors who access those services. It's about understanding needs as they evolve, getting help to people faster and working together to stop violence before it starts.' In September 2024, the government declared intimate partner violence an epidemic in Nova Scotia. Since October, police in Nova Scotia have reported the deaths of seven women and one man, allegedly from intimate partner violence. 'Gender-based violence is a complex issue, but it's one I know we can solve if we listen to the experts and find solutions, together,' said Leah Martin, minister responsible for the Advisory Council on the Status of Women. The province has also introduced domestic violence court programs in Halifax and Sydney and legal changes that allow victims of domestic violence to take leave from work without fear of losing their jobs. The engagement table will be supported by: the minister responsible for the Advisory Council on the Status of Women the minister of Opportunities and Social Development the minister of Health and Wellness the minister of Addictions and Mental Health the minister of Education and Early Childhood Development the minister of L'nu Affairs the minister of African Nova Scotian Affairs A call for applications to join the table will be issued in the coming weeks. The group will meet at least every three months. For more Nova Scotia news, visit our dedicated provincial page
Global News
6 days ago
- Global News
Ozempic, Wegovy linked to rare cases of eye disorder, EMA says
The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy and its treatments for type 2 diabetes may cause rare occurrences of a potentially dangerous eye condition. Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide, the active ingredient in Wegovy and Novo's diabetes drugs Ozempic and Rybelsus, the regulator said on Friday. The EMA, which started its review in December, said the use of the drugs is linked to about twofold increase in the risk of developing the condition compared to people not taking the medicine. NAION develops from insufficient blood flow to the optic nerve and causes sudden painless vision loss in one eye. It is the second most common cause of blindness due to optic nerve damage, after glaucoma. Story continues below advertisement 1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer's risk for those with diabetes Studies have linked semaglutide to NAION in the past. But this is the first time a regulator has made the link. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which work by helping control blood sugar levels and triggering a feeling of fullness. A large study of nearly 350,000 diabetics published earlier this year had showed that the risk of developing NAION more than doubled after long-term use of semaglutide, compared to patients taking medicines from other classes. The EMA said it has reviewed all available data on NAION with semaglutide, including data from non-clinical studies, clinical trials and post-marketing surveillance. It has recommended the drugmaker to update prescribing information for medicines containing semaglutide to include NAION as a side effect with a frequency of 'very rare.' Story continues below advertisement The U.S. Food and Drug Administration did not immediately respond to a Reuters request for comment.
Montreal Gazette
01-06-2025
- Montreal Gazette
Fitness: Fight back against Alzheimer's with exercise
It's never too early to lower the risk of Alzheimer's, which is a neurodegenerative disease characterized by memory loss and cognitive decline, and accounts for 60-80 per cent of dementia cases. With no cure in sight, the immediate focus is on prevention and delaying the disease's progression. Most preventative efforts centre around lifestyle changes relating to several modifiable risk factors, including diabetes, high blood pressure, obesity, smoking and inactivity. And since physical activity has an effect on all these risk factors, it's considered an important element in the fight against Alzheimer's, with studies reporting regular exercise reduces the risk of the disease by as much as 45 per cent. Exercise has long been associated with better mental acuity, largely because of the increase in blood flow to the brain. So even those who show no signs of memory deficit can experience a cognitive boost from a bout of exercise, though its effects largely dissipate within an hour or two post workout. As welcoming as those results are, it's the effects of years of regular exercise that can really make it a difference when it comes to Alzheimer's prevention. Habitual exercisers demonstrate less brain atrophy when compared with their sedentary age-matched peers, especially in the regions of the brain linked to learning and memory. As we age, brain volume naturally decreases as does blood flow to the brain, so any intervention that mitigates its shrinking and improves circulation through all areas of the brain potentially reduces memory loss. This is especially important during midlife when many of the neurological changes associated with Alzheimer's begin. Several studies have shown active older adults have more stable cerebral blood flow compared with their less active peers. But like most studies on the effect of exercise on health, information about the type, intensity and volume of exercise it takes to realize any benefits are the next logical steps in learning more about its efficacy. Yet, as the progression from when the disease first begins developing, to symptoms and then diagnosis can take decades, studying the effect of exercise on Alzheimer's isn't easy — or quick. But there are brain markers that signal physiological changes related to Alzheimer's and tests of cognitive performance that can suggest a predisposition to the disease, both of which can be used when testing the effect of exercise on brain health. Hoping to shed more light on Alzheimer's prevention and treatment, a team of researchers from the department of Kinesiology at the University of North Carolina analyzed the latest studies exploring the effect aerobic exercise and strength training have on brain function and structure. Much of the research on the effects exercise has on memory and brain health has focused on aerobic exercise, largely because of its ability to increase the delivery of oxygenated blood to the brain. A five-month exercise intervention reported significant improvements in cognitive skills and working memory in a group of older adults who went swimming twice a week when compared with those who participated in a stretching program. Similar results have been reported in adults already showing signs of memory loss, which suggests even in those already exhibiting symptoms of cognitive decline, aerobic exercise can offer marked improvement. The benefits of cardio on brain health have also been validated by sophisticated imaging. MRIs (magnetic resonance imaging) performed on 59 sedentary older adults assigned to an aerobic exercise group showed significant increases in brain volume (gray and white mass and hippocampal volume), which researchers suggest is enough to protect against 'one or two years of age-related atrophy.' 'These findings suggest that aerobic exercise preserves memory-related structures and maintains brain health and cognitive resilience in aging populations,' the researchers said. But it's not just cardio that increases brain function. Weight training, particularly workouts that build lower body strength, has also shown positive improvements in working memory and brain structures. As for exercise intensity and volume, workouts need to be at a moderate to high intensity and performed several times a week for brain function to improve. There's also some evidence physical activity that demands decision making (like sports) and/or a social element offers additional benefits. Interestingly, not all improvements to memory happen immediately post exercise. Studies that used extended follow-ups noted some results showed up only after 12 months of regular exercise. The propensity of evidence on the positive effects exercise has on the brain makes its role in brain health indisputable. But don't wait until you notice memory lapses to gear up your exercise routine. Given Alzheimer's can begin developing as early as 20 years prior to the onset of symptoms, the protective effects of exercise can be reaped well in advance of your golden years. Think of every workout as insurance against memory loss and the progressive decline in brain size that occurs with aging. 'Given the recognition that preclinical changes occur decades prior to the diagnosis of Alzheimer's disease and the lack of effective pharmacological treatments to prevent Alzheimer's disease, early intervention through lifestyle behaviours may be critical for preventing Alzheimer's disease in the growing population of older adults,' the researchers said.
